Reducing diagnostic delay is key towards decreasing tuberculosis-associated deaths in people living with HIV. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89% who died. In FujiLAM negative patients, the probability of 12-week survival was 86-97%.
|Journal||Clinical infectious diseases : an official publication of the Infectious Diseases Society of America|
|Publication status||E-pub ahead of print - 9 Jan 2020|